By Shalini Bhardwaj

Pune (Maharashtra) [India], June 23 (ANI): Indian scientists are developing vaccine and antivirals for Chandipura virus, which causes encephalitis, according to Dr Naveen Kumar, ICMR-NIV Pune Director.

Also Read | Did Iran Shoot Down US B-2 Stealth Bomber? AI-Generated Video Circulated To Spread Fake News, Here's a Fact Check of Viral Claim.

"Both vaccine and antivirals for Chandipura virus are in the development phase and not available in the market at the moment," Kumar told ANI.

Fevipiravir is the drug that has been found effective in inhibiting the virus's growth in cell and animal models, he said, adding that the human trials for the drug are expected to begin soon.

Also Read | Delhi Weather Forecast: Monsoon Likely To Arrive in National Capital on June 24; IMD Issues Yellow Alert for Rain, Thunderstorms.

The virus, first identified in 1965, affects children between 5 and 15 years old and can cause encephalitis, leading to death within 24-48 hours.

"The challenge with Chandipura disease is that we have a diagnosis because this is an old disease, but we don't have antivirals or vaccines. But ICMR is speedily working on its research work, and multi-sectoral efforts are underway." Said Dr Pragya Yadav, Director in charge, National Institute of One Health, Nagpur

The Chandipura virus is transmitted through the bite of sandflies. Its symptoms are fever, vomiting, and loss of consciousness.

The most affected regions are States like Maharashtra, Gujarat, Madhya Pradesh, Chhattisgarh, Andhra Pradesh, Telangana, Odisha, Bihar, Jharkhand, and eastern Uttar Pradesh. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)